Briefing

Industry news

Industry briefing

Covid-19 briefing

NEWS

China approves AstraZeneca’s Imfinzi for small-cell lung cancer

COVID-19

India gains ground in Covid-19 clinical trials

With approximately 615 trials underway, India has now overtaken Iran and China in the total number of Covid-19 trials

BRIEFING

UK fines drugmakers for price gouging the NHS

The UK’s competition watchdog has fined pharma companies more than £260m for price gouging

Industry news

Industry briefing

Covid-19 briefing

02/23/2024 22:40:34
  • Home | Waive goodbye to vaccine patents
  • In this issue
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Datwyler
  • Datwyler Company Insight
  • Labcorp
  • Biesterfeld
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Dr. Paul Lohmann
  • Butterworth
  • Skyepharma
  • Baxter
  • Comment
  • Speeding up patient access to innovative drugs
  • The competitive landscape of neoantigen-targeting therapeutics in oncology
  • Bacterial “cell factories”: an eco-friendly approach to chemical production
  • MDR set to transform how MedTech firms approach content management
  • PerkinElmer
  • Nipro
  • Nipro
  • In Depth
  • Should UK children be vaccinated against chickenpox?
  • Fighting India’s ‘black fungus’ epidemic
  • What could a vaccine patent waiver mean for pharma manufacturing? 
  • Algae proteins: a vision of the future
  • A brief history of ALS awareness and its sparse treatments 
  • Ferring draws closer to a microbiome breakthrough
  • The Solubility company
  • Myonex
  • Owen Mumford
  • In Data
  • Data: pharma subsidiaries
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
07/22/2021 00:00:00